Luke Miels, Chief Commercial Officer, GSK, stated, "This revised agreement with Zhifei puts our collaboration on a sustainable footing, managing challenges in the macro environment in the near ...

GSK has expanded its voluntary licensing agreement with the United Nations-backed Medicines Patent Pool (MPP) for ...

GSK raised its 2024 full-year guidance thanks to rising demand for its oncology portfolio and long-acting HIV medications. Read more on GSK stock here.

GSK has shifted towards a global marketing model influenced by a Netflix-style approach that aims to match content to the person receiving it. Richard Staines heard about this new strategy at the ...

Dr. Gur Levy, Respiratory Medical Expert at GSK, said, "We have been pioneering efforts for decades to develop new therapeutic alternatives that set the standard for next-generation treatments and ...

Dr. Marc Gitzinger, Chief Executive Officer and founder of BioVersys: "We are very pleased to announce both the expansion of our highly successful strategic collaboration with GSK and our partner ...

Recent developments illustrate dynamic shifts in the healthcare sector. Trump's spending bill is anticipated to challenge ...

Shares of Wave Life Sciences Ltd. jumped about 17% in premarket trading on Tuesday after the company announced a four-year strategic collaboration with GlaxoSmithKline to develop oligonucleotide ...

Delaware's top court is set to hear an appeal from GSK and other pharmaceutical giants to throw out over 70,000 lawsuits alleging that the now-discontinued heartburn drug Zantac caused cancer ...

Luke Miels, Chief Commercial Officer, GSK, stated, "This revised agreement with Zhifei puts our collaboration on a sustainable footing, managing challenges in the macro environment in the near ...

GSK hosted the third annual RespiVerse Meeting on December 13 and 14 in Bangkok, Thailand. The event brought together renowned international speakers and healthcare professionals from 17 countries to ...

Strategic collaboration with GSK expanded to accelerate clinical development of alpibectir for the treatment of tuberculosis GSK to participate in Series C Extension with equity investment Series ...